Skip to content

13F-HR filed by Blackcrane Capital, LLC

Blackcrane Capital, LLC filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-12, with 8 holding rows worth $42,859,000.

Accession
0001720745-20-000005
Filed
2020-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, 9 entries on the cover page, a total value of $42,859,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $42,859,000 with VALUE read as thousands by filing date, 13F file number 028-18913. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AVITA THERAPEUTICS, INC.05380C102COM474,982$11,951,000thousands by filing date
WIX COM LTD SHSM98068105Stock41,610$10,604,000thousands by filing date
AXONICS INC05465P101COM124,787$6,369,000thousands by filing date
NICE LTD SPONSORED ADR653656108ADR25,952$5,892,000thousands by filing date
PROFOUND MED CORP74319B502COM NEW196,924$3,474,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM44,112$2,868,000thousands by filing date
Microsoft Corp594918104COM5,904$1,242,000thousands by filing date
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS874060205ADR25,723$459,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001720745-20-000005this filing2020-11-12acceptance time not in the bulk data set